🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In this clinical review, authors dive into epidemiology, pathogenesis, clinical features, and treatments for nail unit verruca: bit.ly/4cI1MQo

JAAD Case Report: What is the most likely diagnosis? Find out: bit.ly/4lGILBV

JAAD’s CME supplement on Hidradenitis Suppurativa offers 11 CME credits and valuable insights on HS care & management. Read updates on therapies, epidemiology, earn CME and more: bit.ly/49D791O

Drug-induced hypersensitivity syndrome (DIHS/DRESS) is a reaction to medication and CMV disease is a key prognostic factor. But what drives CMV progression in DIHS/DRESS? Read the JAAD International article: bit.ly/3YG1FPi

Hansen's disease (leprosy) is chronic intracellular infection caused by Mycobacterium leprae and Mycobacterium lepromatosis, chiefly affecting skin and peripheral nerves. Learn more in the recent issue of JAAD: bit.ly/3GmKsnS

Lichen planus (LP) is a chronic autoimmune disease that can affect nails in up to 15% of cases—often signaling severity. This article in JAAD Reviews looks at lichenoid nail changes and how to recognize them. Read more via the link in our bio: bit.ly/4lyhZLU

New JAAD CME article on Psoriatic Arthritis (PsA): Early detection is key to preventing joint damage and improving quality of life. Dermatologists play a crucial role, as psoriasis often precedes PsA in 80% of cases. Learn more and earn CME credit: bit.ly/3Ypzu7r

This analysis investigates the efficacy of lebrikizumab-treated patients at 52 weeks who did not achieve protocol-defined response criteria after 16 weeks. Learn more in JAAD: bit.ly/3YriE86

What is the most likely diagnosis? Read the JAAD Case Report to find out: bit.ly/4k5ERAZ

This JAAD International study assessed the efficacy of 25 mg/d bicalutamide combined with 1 mg/d minoxidil compared to 1 mg/d minoxidil monotherapy over 24 weeks for FPHL treatment: bit.ly/4jL6b7O

This study assessed the role of wearing “finger-socks” in addition to topical antifungal treatment in managing interdigital tinea pedis. bit.ly/3Z6KaYI

Big news! The AAD CME Supplement on Alopecia is now open access for another year. This supplement encompasses patient evaluation, treatment, and drug information surrounding alopecia. bit.ly/3KJIeOA

Psoriatic arthritis affects up to 1 in 3 psoriasis patients—often after skin symptoms appear. Dermatologists play a key role in early detection and management. Learn about screening, treatment, and comanagement in the CME article: bit.ly/4jROGD1

JAAD Case Report: What is the most likely diagnosis? Tell us your answer. bit.ly/3GUUSLK

This game-changing article reshaped clinical conversations around acne and diet. With data linking low and nonfat dairy to worsening acne, dermatologists now have firmer ground for dietary recommendations. bit.ly/44GsJSu

Applications are open! The JAAD Editorial Mentorship Program pairs young and experienced dermatologists with editorial mentors to build peer review & critical appraisal skills. Apply by May 30: bit.ly/3rBJBp2

New meta-analysis evaluates the prevalence of poor outcomes in cSCC patients by the American Joint Committee on Cancer (AJCC) and Brigham and Women's Hospital (BWH) tumor stages: bit.ly/43ilDB9

A large majority of people with plaque psoriasis (80-90%) or psoriatic arthritis (80%) also have nail psoriasis. New research looks at natural treatments like oral omega-3s, vitamins, indigo naturalis and diet. Learn more in JAAD Reviews: bit.ly/3EZLuWL

Studies have suggested that in HS, inflammation is directed toward hair follicles. The disease activity tends to persist until all the hair-bearing skin is replaced with hairless scars. Watch this surgical solution featured in JAAD: bit.ly/4dqbRSr

Botulinum toxin A injections showed the most effective improvement in nail psoriasis, outperforming steroid injections, topical treatments, and placebo — with a 40% reduction in total target NAPSI score at 24 weeks. Read more in JAADi: bit.ly/44Oz9PF